Top Markets
#1 Nesa Nesa +720.45%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +14.20%
#4 Venom Venom +10.59%
#5 Pons Pons +9.49%
#6 PondCoin PondCoin +8.69%
#7 Status Status +8.08%
#8 Wrapped NXM Wrapped NXM +8.03%
#9 Prom Prom +7.99%
#10 Ontology Gas Ontology Gas +7.17%
Coin of the day
Nesa Nesa
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Rangering i aksjer #19834
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aksjekurs
$9.61
Sist synkronisert: 2026-08-25
Markedsverdi
$149.33M
Endring (1 dag)
-1.39%
Endring (1 år)
21.24%
Land
US
Handel Alpha Cognition Inc (ACOG)

Kategori

Healthcare
Inntekter for Alpha Cognition Inc (ACOG)
Inntekter i 2026 TTM: 0
Ifølge Alpha Cognition Inc sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Alpha Cognition Inc fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH